Barriers to drug delivery in solid tumors.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Significant advancements in drug delivery have been achieved using engineered nanoparticles, addressing limitations like pharmacokinetics and solubility.
• Despite progress in tumor targeting, effective treatment strategies for malignant tumors remain challenging due to distinct tumor physiology and biological system complexity.
• Site-specific delivery of therapeutic drugs faces hurdles from these physiological and biological complexities.

Purpose of the Study:

• To provide a comprehensive understanding of biological barriers in drug delivery.
• To outline methods for exploiting nanoparticle characteristics to overcome these barriers.
• To guide the design of multifunctional nanocarriers for improved therapeutic outcomes.

Main Methods:

• Review of current literature on nanoparticle drug delivery systems.
• Analysis of biological barriers encountered in tumor targeting.
• Exploration of strategies for designing multifunctional nanocarriers.
• Discussion of dosing regimens for enhanced efficacy.

Main Results:

• Engineered nanoparticles offer tailored functionalities to circumvent drug delivery limitations.
• Understanding and exploiting biological barriers is crucial for effective nanocarrier design.
• Multifunctional nanocarriers can be designed to improve drug targeting and therapeutic efficacy.
• Optimized dosing regimens are essential for successful clinical translation.

Conclusions:

• Nanoparticle engineering provides a powerful platform for advancing drug delivery.
• Overcoming biological barriers is key to realizing the full potential of nanomedicine in oncology.
• Multifunctional nanocarriers and optimized dosing regimens promise improved clinical outcomes for cancer treatment.